The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
"We as Democrats have to be honest enough to acknowledge that coverage does not automatically mean adequate or timely care," said Democratic strategist Garry South, a longtime Newsom ally.
Generics and biosimilar drugs are available at a substantially lower price for many drugs, but are often excluded from formularies by the very vendor we entrust to manage our costs.
Democratic senators on Wednesday took a formal step toward reviving President Joe Biden's economic agenda, starting with a measure to let Medicare negotiate prices with drugmakers and to curb rising drug costs more broadly.